ArticleNPJ precision oncology2026
Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning.
Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.